HIMS
Hims & Hers Health, Inc.NYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
32.74
PEG
17.73
P/B
8.03
P/S
1.79
EV/EBITDA
32.63
DCF Value
$112.19
FCF Yield
1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.8%
Operating Margin
4.5%
Net Margin
5.5%
ROE
23.0%
ROA
7.6%
ROIC
6.0%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $617.8M | $20.6M | $0.08 |
| FY 2025 | $2.35B | $128.4M | $0.51 |
| Q3 2025 | $599.0M | $15.8M | $0.06 |
| Q2 2025 | $544.8M | $42.5M | $0.17 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllLatest News
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
2.31
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.